Excellent Response to Dual Her2 Targeted Therapy in a Patient with Advanced Colorectal Cancer in Fourth Line of Treatment

Juárez A, Montero M, Llorente M, Gálvez E, Durán R and Llorca C

Department of Medical Oncology, Elda Hospital, Spain
Department of Pathological Anatomy, Elda Hospital, Spain

^*Correspondance to: Juarez A 

 PDF  Full Text Case Report | Open Access

Abstract:

Men 47 years old with staged IV colon cancer Ras wild type and her 23+, who had progressed to all approved treatments, get an spectacular response with dual her2 targeted Therapy without chemotherapy. This is the first case reported with this treatment, supporting the results of HERACLES study, as well as encouraging the development of phase III studies.

Keywords:

Colon cáncer; Her2; Trastuzumab; Lapatinib

Cite the Article:

Juárez A, Montero M, Llorente M, Gálvez E, Durán R, Llorca C. Excellent Response to Dual Her2 Targeted Therapy in a Patient with Advanced Colorectal Cancer in Fourth Line of Treatment. Clin Oncol. 2016;1: 1160.